Meningitis outbreak stirs calls for FDA pharmacy oversight

By David Morgan and Sharon Begley

WASHINGTON/NEW YORK | Tue Oct 9, 2012 1:21am EDT

WASHINGTON/NEW YORK (Reuters) - A deadly U.S. meningitis outbreak tied to contaminated steroid shots should spur new legislation to regulate how pharmacies mix and dose drugs, experts said on Monday.

To read this article click here.